[
  {
    "drug": "Pergolide",
    "disease": "hypertension",
    "confidence": 0.9892363605998477,
    "confidence_tier": "Very High",
    "boosted_score": 1.1895567764481645,
    "base_score": 0.9871840468449496,
    "target_overlap": 8,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Drug withdrawn from US market due to safety concerns"
  },
  {
    "drug": "Piperacillin",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9876560468127669,
    "confidence_tier": "Very High",
    "boosted_score": 1.1121535350402665,
    "base_score": 0.9885809200357925,
    "target_overlap": 0,
    "chemical_sim": 0.02666666666666667,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Gentamicin",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9869908301097147,
    "confidence_tier": "Very High",
    "boosted_score": 1.1178238505108327,
    "base_score": 0.9936212004540734,
    "target_overlap": 0,
    "chemical_sim": 0.045454545454545456,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Imipramine",
    "disease": "hypertension",
    "confidence": 0.9869608701883652,
    "confidence_tier": "Very High",
    "boosted_score": 1.1967155767409114,
    "base_score": 0.97691067489054,
    "target_overlap": 10,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "TCAs can CAUSE hypertension via NET inhibition (HARMFUL)"
  },
  {
    "drug": "Gemifloxacin",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.986801116496055,
    "confidence_tier": "Very High",
    "boosted_score": 1.1199220905731215,
    "base_score": 0.9867154983023098,
    "target_overlap": 1,
    "chemical_sim": 0.05333333333333334,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Pazufloxacin",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9856049703515786,
    "confidence_tier": "Very High",
    "boosted_score": 1.110047093818276,
    "base_score": 0.9780150606328424,
    "target_overlap": 1,
    "chemical_sim": 0.046875,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Bleomycin",
    "disease": "type 1 diabetes mellitus",
    "confidence": 0.9849340160819792,
    "confidence_tier": "Very High",
    "boosted_score": 1.0029581680411592,
    "base_score": 0.9690417082523278,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "antibiotic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Cefdinir",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9847807443044558,
    "confidence_tier": "Very High",
    "boosted_score": 1.0997786988901768,
    "base_score": 0.9775810656801571,
    "target_overlap": 0,
    "chemical_sim": 0.041666666666666664,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Oxacillin",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9847272288303721,
    "confidence_tier": "Very High",
    "boosted_score": 1.0487265548177478,
    "base_score": 0.9847197697819229,
    "target_overlap": 0,
    "chemical_sim": 0.04477611940298507,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Sulfamethoxazole",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9844466208198954,
    "confidence_tier": "Very High",
    "boosted_score": 1.1199001981101429,
    "base_score": 0.9780787756420461,
    "target_overlap": 2,
    "chemical_sim": 0.06521739130434782,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Metampicillin",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.984327762518368,
    "confidence_tier": "Very High",
    "boosted_score": 1.0044715899777792,
    "base_score": 0.9799722829051505,
    "target_overlap": 0,
    "chemical_sim": 0.04838709677419355,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Demeclocycline",
    "disease": "type 1 diabetes mellitus",
    "confidence": 0.9840788278789523,
    "confidence_tier": "Very High",
    "boosted_score": 0.9918249658506092,
    "base_score": 0.9676341130249847,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "antibiotic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Cefapirin",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9834411867219962,
    "confidence_tier": "Very High",
    "boosted_score": 1.068491583025424,
    "base_score": 0.9847848691478563,
    "target_overlap": 0,
    "chemical_sim": 0.0273972602739726,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Azidocillin",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9833473175728615,
    "confidence_tier": "Very High",
    "boosted_score": 1.0287413667272864,
    "base_score": 0.9844414992605612,
    "target_overlap": 0,
    "chemical_sim": 0.046153846153846156,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Pefloxacin",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9825670030261042,
    "confidence_tier": "Very High",
    "boosted_score": 1.1144420138206672,
    "base_score": 0.9818872368464029,
    "target_overlap": 1,
    "chemical_sim": 0.03333333333333333,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Dextropropoxyphene",
    "disease": "major depressive disorder",
    "confidence": 0.9821959939623465,
    "confidence_tier": "Very High",
    "boosted_score": 1.0865142587336367,
    "base_score": 0.965790452207677,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Drug withdrawn from US market due to safety concerns"
  },
  {
    "drug": "Protriptyline",
    "disease": "hypertension",
    "confidence": 0.9819575278483761,
    "confidence_tier": "Very High",
    "boosted_score": 1.1535513778691755,
    "base_score": 0.9901728565400648,
    "target_overlap": 4,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "TCAs can CAUSE hypertension via NET inhibition (HARMFUL)"
  },
  {
    "drug": "Iodixanol",
    "disease": "hypertension",
    "confidence": 0.9819359039046679,
    "confidence_tier": "Very High",
    "boosted_score": 1.0979507053219724,
    "base_score": 0.9759561825084199,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Cefotetan",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9812715526574938,
    "confidence_tier": "Very High",
    "boosted_score": 1.033072111693116,
    "base_score": 0.9885857528163791,
    "target_overlap": 1,
    "chemical_sim": 0.047619047619047616,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Amitriptyline",
    "disease": "hypertension",
    "confidence": 0.9810468489149333,
    "confidence_tier": "Very High",
    "boosted_score": 1.199916334251306,
    "base_score": 0.9795235381643314,
    "target_overlap": 16,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "TCAs can CAUSE hypertension via NET inhibition (HARMFUL)"
  },
  {
    "drug": "Enrofloxacin",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9802269224404511,
    "confidence_tier": "Very High",
    "boosted_score": 1.0893929060668188,
    "base_score": 0.9814350505106475,
    "target_overlap": 1,
    "chemical_sim": 0.03125,
    "atc_score": 0.0,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Ceftibuten",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9795196775992676,
    "confidence_tier": "Very High",
    "boosted_score": 1.0189113149011368,
    "base_score": 0.9844553767160743,
    "target_overlap": 0,
    "chemical_sim": 0.027777777777777776,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Aldosterone",
    "disease": "ovarian neoplasm",
    "confidence": 0.9793495218331341,
    "confidence_tier": "Very High",
    "boosted_score": 1.0888816057804231,
    "base_score": 0.9427546370393274,
    "target_overlap": 3,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Hormone promotes tumor growth; blocking it is therapeutic (OPPOSITE)"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "rheumatoid arthritis",
    "confidence": 0.9790174067213199,
    "confidence_tier": "Very High",
    "boosted_score": 1.087147536754008,
    "base_score": 0.9663533660035627,
    "target_overlap": 0,
    "chemical_sim": 0.09523809523809523,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "autoimmune",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "invasive breast carcinoma",
    "confidence": 0.978741124549373,
    "confidence_tier": "Very High",
    "boosted_score": 1.1157143355107586,
    "base_score": 0.9830082251196111,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Arbutamine",
    "disease": "hypertension",
    "confidence": 0.9785639702877502,
    "confidence_tier": "Very High",
    "boosted_score": 1.156680333646349,
    "base_score": 0.9886156697832041,
    "target_overlap": 2,
    "chemical_sim": 0.0,
    "atc_score": 1.0,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Cardiac stress testing agent - RAISES BP, doesn't treat hypertension"
  },
  {
    "drug": "Cefoxitin",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9781944186623084,
    "confidence_tier": "Very High",
    "boosted_score": 1.0064405081372902,
    "base_score": 0.9818931786705272,
    "target_overlap": 0,
    "chemical_sim": 0.05405405405405406,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Pseudoephedrine",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9780143830902546,
    "confidence_tier": "Very High",
    "boosted_score": 1.152393884065406,
    "base_score": 0.9891792996269579,
    "target_overlap": 4,
    "chemical_sim": 0.05405405405405406,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Sympathomimetics increase blood glucose (HARMFUL)"
  },
  {
    "drug": "Valdecoxib",
    "disease": "stroke disorder",
    "confidence": 0.9778958546661364,
    "confidence_tier": "Very High",
    "boosted_score": 1.032371055386731,
    "base_score": 0.9176631603437607,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "kinase_inhibitor",
    "disease_category": "other",
    "exclusion_reason": "Drug withdrawn from US market due to safety concerns"
  },
  {
    "drug": "Iodixanol",
    "disease": "major depressive disorder",
    "confidence": 0.9777872005350909,
    "confidence_tier": "Very High",
    "boosted_score": 1.0376638293192535,
    "base_score": 0.956372192920971,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Cefditoren",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9776603683131749,
    "confidence_tier": "Very High",
    "boosted_score": 1.00403601379899,
    "base_score": 0.9795473305356003,
    "target_overlap": 0,
    "chemical_sim": 0.047619047619047616,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Minocycline",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9775915818361873,
    "confidence_tier": "Very High",
    "boosted_score": 1.1548985212704195,
    "base_score": 0.9787275603986605,
    "target_overlap": 3,
    "chemical_sim": 0.08823529411764706,
    "atc_score": 1.0,
    "drug_type": "antibiotic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Moxifloxacin",
    "disease": "diabetic ketoacidosis",
    "confidence": 0.9773634708041241,
    "confidence_tier": "Very High",
    "boosted_score": 1.0034780002427317,
    "base_score": 0.9790029270660798,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Cefmenoxime",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9772535714464577,
    "confidence_tier": "Very High",
    "boosted_score": 1.0021878055992248,
    "base_score": 0.9777442005846098,
    "target_overlap": 0,
    "chemical_sim": 0.04597701149425287,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "ulcerative colitis",
    "confidence": 0.9770800346885933,
    "confidence_tier": "Very High",
    "boosted_score": 1.0710963657443189,
    "base_score": 0.9606245432684474,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "autoimmune",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "malaria susceptibility to",
    "confidence": 0.9757299350190214,
    "confidence_tier": "Very High",
    "boosted_score": 1.0498962077955796,
    "base_score": 0.9332410735960707,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Dextropropoxyphene",
    "disease": "hypertension",
    "confidence": 0.9755472305161971,
    "confidence_tier": "Very High",
    "boosted_score": 1.133719126586973,
    "base_score": 0.9815750013740027,
    "target_overlap": 3,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Drug withdrawn from US market due to safety concerns"
  },
  {
    "drug": "Doxycycline",
    "disease": "diabetic ketoacidosis",
    "confidence": 0.9753322598036948,
    "confidence_tier": "Very High",
    "boosted_score": 0.9464191856163486,
    "base_score": 0.9233357908452182,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "antibiotic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Pergolide",
    "disease": "obstructive lung disease",
    "confidence": 0.9753299831613439,
    "confidence_tier": "Very High",
    "boosted_score": 1.0646879951285904,
    "base_score": 0.938051097029595,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Drug withdrawn from US market due to safety concerns"
  },
  {
    "drug": "Aldosterone",
    "disease": "invasive breast carcinoma",
    "confidence": 0.9753228331992108,
    "confidence_tier": "Very High",
    "boosted_score": 1.1144706320413702,
    "base_score": 0.9649096381310563,
    "target_overlap": 3,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Hormone promotes tumor growth; blocking it is therapeutic (OPPOSITE)"
  },
  {
    "drug": "Dexlansoprazole",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9748990900176291,
    "confidence_tier": "Very High",
    "boosted_score": 1.1340394076955556,
    "base_score": 0.9776201790478926,
    "target_overlap": 1,
    "chemical_sim": 0.015384615384615385,
    "atc_score": 1.0,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "epilepsy",
    "confidence": 0.9743399873429358,
    "confidence_tier": "Very High",
    "boosted_score": 1.0438201513080207,
    "base_score": 0.9278401344960184,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "ovarian neoplasm",
    "confidence": 0.9736649079185794,
    "confidence_tier": "Very High",
    "boosted_score": 1.0403926012013869,
    "base_score": 0.9247934232901217,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Levofloxacin",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9732926983420169,
    "confidence_tier": "Very High",
    "boosted_score": 1.1498955684034011,
    "base_score": 0.9870348226638636,
    "target_overlap": 4,
    "chemical_sim": 0.030303030303030304,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Dobutamine",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9727905481858637,
    "confidence_tier": "Very High",
    "boosted_score": 1.1305419073840268,
    "base_score": 0.983079919464371,
    "target_overlap": 0,
    "chemical_sim": 0.04081632653061224,
    "atc_score": 1.0,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Sympathomimetics increase blood glucose (HARMFUL)"
  },
  {
    "drug": "Doxazosin",
    "disease": "heart failure",
    "confidence": 0.972184064515554,
    "confidence_tier": "Very High",
    "boosted_score": 1.1222714411903283,
    "base_score": 0.9758882097307202,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 1.0,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "ALLHAT trial: Alpha blockers increase HF risk 2x (HARMFUL)"
  },
  {
    "drug": "Reslizumab",
    "disease": "ulcerative colitis",
    "confidence": 0.9712100349823003,
    "confidence_tier": "Very High",
    "boosted_score": 1.0887507173141142,
    "base_score": 0.9677784153903237,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "autoimmune",
    "exclusion_reason": "Anti-IL-5 reduces eosinophils but fails clinically for this disease"
  },
  {
    "drug": "Aldosterone",
    "disease": "chronic lymphocytic leukemia/small lymphocytic lymphoma",
    "confidence": 0.9708130311328425,
    "confidence_tier": "Very High",
    "boosted_score": 1.0797975585889446,
    "base_score": 0.9513634877435635,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Hormone promotes tumor growth; blocking it is therapeutic (OPPOSITE)"
  },
  {
    "drug": "Gentamicin",
    "disease": "diabetes mellitus",
    "confidence": 0.9706897719768979,
    "confidence_tier": "Very High",
    "boosted_score": 1.0316368195107068,
    "base_score": 0.9170105062317394,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Sibutramine",
    "disease": "epilepsy",
    "confidence": 0.96982914512028,
    "confidence_tier": "Very High",
    "boosted_score": 1.0667447663620209,
    "base_score": 0.92358854230478,
    "target_overlap": 3,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Drug withdrawn from US market due to safety concerns"
  },
  {
    "drug": "Bleomycin",
    "disease": "diabetes mellitus",
    "confidence": 0.9683294021368669,
    "confidence_tier": "Very High",
    "boosted_score": 0.9303667343251981,
    "base_score": 0.8903030950480365,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "antibiotic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Ioflupane I 123",
    "disease": "obstructive lung disease",
    "confidence": 0.9681358018097894,
    "confidence_tier": "Very High",
    "boosted_score": 1.0224820855768098,
    "base_score": 0.9467426718303793,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Gentamicin",
    "disease": "diabetic ketoacidosis",
    "confidence": 0.9676337799737452,
    "confidence_tier": "Very High",
    "boosted_score": 0.9661232718796735,
    "base_score": 0.9425592896387059,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Pergolide",
    "disease": "epilepsy",
    "confidence": 0.9675285789369299,
    "confidence_tier": "Very High",
    "boosted_score": 1.1307235443512087,
    "base_score": 0.9501878523959736,
    "target_overlap": 4,
    "chemical_sim": 0.0,
    "atc_score": 1.0,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Drug withdrawn from US market due to safety concerns"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "asthma",
    "confidence": 0.967341792313145,
    "confidence_tier": "Very High",
    "boosted_score": 0.986047645668162,
    "base_score": 0.9258663339607156,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "thyroid gland carcinoma",
    "confidence": 0.966905497828318,
    "confidence_tier": "Very High",
    "boosted_score": 1.0542931020537607,
    "base_score": 0.9455543516177226,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Tetracycline",
    "disease": "diabetic ketoacidosis",
    "confidence": 0.9664118830446793,
    "confidence_tier": "Very High",
    "boosted_score": 0.9141145839837097,
    "base_score": 0.8918191063255705,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "antibiotic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "stomach carcinoma in situ",
    "confidence": 0.9658680861646046,
    "confidence_tier": "Very High",
    "boosted_score": 1.0589739386978836,
    "base_score": 0.941310167731452,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Iodixanol",
    "disease": "asthma",
    "confidence": 0.9658650773014535,
    "confidence_tier": "Very High",
    "boosted_score": 1.0267208077494618,
    "base_score": 0.9126407179995216,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Brolucizumab",
    "disease": "multiple sclerosis",
    "confidence": 0.9649201161438307,
    "confidence_tier": "Very High",
    "boosted_score": 1.0527920603152072,
    "base_score": 0.9358151647246286,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Intravitreal formulation - not suitable for systemic disease"
  },
  {
    "drug": "Brolucizumab",
    "disease": "ulcerative colitis",
    "confidence": 0.9647765170897676,
    "confidence_tier": "Very High",
    "boosted_score": 1.0736829704164068,
    "base_score": 0.9543848625923615,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "autoimmune",
    "exclusion_reason": "Intravitreal formulation - not suitable for systemic disease"
  },
  {
    "drug": "Mepolizumab",
    "disease": "psoriasis",
    "confidence": 0.9641099759906019,
    "confidence_tier": "Very High",
    "boosted_score": 1.0431788776052164,
    "base_score": 0.927270113426859,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Anti-IL-5 reduces eosinophils but fails clinically for this disease"
  },
  {
    "drug": "Reslizumab",
    "disease": "psoriasis",
    "confidence": 0.9639660631954724,
    "confidence_tier": "Very High",
    "boosted_score": 1.0427372781117636,
    "base_score": 0.9268775805437899,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Anti-IL-5 reduces eosinophils but fails clinically for this disease"
  },
  {
    "drug": "5-(5-(4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole",
    "disease": "type 1 diabetes mellitus",
    "confidence": 0.963518741247903,
    "confidence_tier": "Very High",
    "boosted_score": 0.9654345756973273,
    "base_score": 0.9654345756973273,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Rabeprazole",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9634793889158779,
    "confidence_tier": "Very High",
    "boosted_score": 1.1548309548680933,
    "base_score": 0.9786703007356722,
    "target_overlap": 3,
    "chemical_sim": 0.015384615384615385,
    "atc_score": 1.0,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Reslizumab",
    "disease": "multiple sclerosis",
    "confidence": 0.9634722194439895,
    "confidence_tier": "Very High",
    "boosted_score": 1.0412347093870062,
    "base_score": 0.9255419638995611,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Anti-IL-5 reduces eosinophils but fails clinically for this disease"
  },
  {
    "drug": "Technetium Tc-99m sestamibi",
    "disease": "rheumatoid arthritis",
    "confidence": 0.9629853871149956,
    "confidence_tier": "Very High",
    "boosted_score": 0.9639976274218387,
    "base_score": 0.9639976274218387,
    "target_overlap": 0,
    "chemical_sim": 0.04878048780487805,
    "atc_score": 0.0,
    "drug_type": "small_molecule",
    "disease_category": "autoimmune",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Brolucizumab",
    "disease": "psoriasis",
    "confidence": 0.9624364985317357,
    "confidence_tier": "Very High",
    "boosted_score": 1.0499277809782546,
    "base_score": 0.9250465030645414,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Intravitreal formulation - not suitable for systemic disease"
  },
  {
    "drug": "Fluconazole",
    "disease": "diabetes mellitus",
    "confidence": 0.9618710321956837,
    "confidence_tier": "Very High",
    "boosted_score": 1.0164295652272897,
    "base_score": 0.8877114106788555,
    "target_overlap": 2,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Valdecoxib",
    "disease": "osteoarthritis",
    "confidence": 0.9614863819525418,
    "confidence_tier": "Very High",
    "boosted_score": 0.9994670131320669,
    "base_score": 0.8805876767683408,
    "target_overlap": 1,
    "chemical_sim": 0.1111111111111111,
    "atc_score": 0.5,
    "drug_type": "kinase_inhibitor",
    "disease_category": "autoimmune",
    "exclusion_reason": "Drug withdrawn from US market due to safety concerns"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "descending colon cancer",
    "confidence": 0.9613630925911598,
    "confidence_tier": "Very High",
    "boosted_score": 1.0499750479157623,
    "base_score": 0.9250881479434029,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Aducanumab",
    "disease": "psoriasis",
    "confidence": 0.9602990443619323,
    "confidence_tier": "Very High",
    "boosted_score": 0.9591084483880716,
    "base_score": 0.9357155594029968,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Aldosterone",
    "disease": "lung cancer",
    "confidence": 0.9599570989814911,
    "confidence_tier": "Very High",
    "boosted_score": 1.0513439196129222,
    "base_score": 0.9262942023021341,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Hormone promotes tumor growth; blocking it is therapeutic (OPPOSITE)"
  },
  {
    "drug": "Idarubicin",
    "disease": "type 2 diabetes mellitus",
    "confidence": 0.9594889632754119,
    "confidence_tier": "Very High",
    "boosted_score": 1.2100015167823914,
    "base_score": 0.9877563402305236,
    "target_overlap": 19,
    "chemical_sim": 0.04054054054054054,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Chemotherapy drug has no mechanism for metabolic disease"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "plasma cell myeloma",
    "confidence": 0.9591251525946273,
    "confidence_tier": "Very High",
    "boosted_score": 0.9943903453550625,
    "base_score": 0.8839025292045001,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Ioflupane I 123",
    "disease": "parkinson disease",
    "confidence": 0.9588513060708909,
    "confidence_tier": "Very High",
    "boosted_score": 0.9995437413303976,
    "base_score": 0.9170126067251353,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Romosozumab",
    "disease": "multiple sclerosis",
    "confidence": 0.9577121415015812,
    "confidence_tier": "Very High",
    "boosted_score": 0.9824738114834897,
    "base_score": 0.9401663267784591,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Bone metabolism drug has no CNS mechanism for neurological diseases"
  },
  {
    "drug": "Bectumomab",
    "disease": "psoriasis",
    "confidence": 0.9573340335156469,
    "confidence_tier": "Very High",
    "boosted_score": 0.963407460348564,
    "base_score": 0.963407460348564,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Lexatumumab",
    "disease": "ulcerative colitis",
    "confidence": 0.9569381876625715,
    "confidence_tier": "Very High",
    "boosted_score": 1.056227449131747,
    "base_score": 0.9602067719379517,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "autoimmune",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Fontolizumab",
    "disease": "multiple sclerosis",
    "confidence": 0.9566423895890374,
    "confidence_tier": "Very High",
    "boosted_score": 1.0520769050738559,
    "base_score": 0.9478170315980683,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Aldosterone",
    "disease": "prostate carcinoma",
    "confidence": 0.9565551582366973,
    "confidence_tier": "Very High",
    "boosted_score": 1.0559897497188762,
    "base_score": 0.9064289697157735,
    "target_overlap": 4,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Hormone promotes tumor growth; blocking it is therapeutic (OPPOSITE)"
  },
  {
    "drug": "Volociximab",
    "disease": "multiple sclerosis",
    "confidence": 0.9565444738021326,
    "confidence_tier": "Very High",
    "boosted_score": 0.9614842259160193,
    "base_score": 0.9614842259160193,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "\u03b15\u03b21 integrin is PROTECTIVE in MS - inhibiting worsens disease"
  },
  {
    "drug": "Aldosterone",
    "disease": "wilms tumor",
    "confidence": 0.9560489399634451,
    "confidence_tier": "Very High",
    "boosted_score": 1.0129601124154841,
    "base_score": 0.9250777282333189,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Hormone promotes tumor growth; blocking it is therapeutic (OPPOSITE)"
  },
  {
    "drug": "Rifampicin",
    "disease": "diabetes mellitus",
    "confidence": 0.9549604881530522,
    "confidence_tier": "Very High",
    "boosted_score": 0.9969376341821305,
    "base_score": 0.8783591490591458,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Lexatumumab",
    "disease": "psoriasis",
    "confidence": 0.9546050934787011,
    "confidence_tier": "Very High",
    "boosted_score": 1.0293065866080027,
    "base_score": 0.9357332605527295,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Fontolizumab",
    "disease": "ulcerative colitis",
    "confidence": 0.9537071207747168,
    "confidence_tier": "Very High",
    "boosted_score": 1.066032326688072,
    "base_score": 0.9603894835027674,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "autoimmune",
    "exclusion_reason": "Anti-IFN-gamma wrong pathway - UC is Th2-like, not Th1"
  },
  {
    "drug": "Enokizumab",
    "disease": "multiple sclerosis",
    "confidence": 0.9535071476142738,
    "confidence_tier": "Very High",
    "boosted_score": 0.9543839987633123,
    "base_score": 0.9543839987633123,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Nebacumab",
    "disease": "multiple sclerosis",
    "confidence": 0.9527376716733439,
    "confidence_tier": "Very High",
    "boosted_score": 0.9405870070208461,
    "base_score": 0.9176458605081426,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Cancer-specific antibody targets tumor marker, not autoimmune pathway"
  },
  {
    "drug": "Adecatumumab",
    "disease": "multiple sclerosis",
    "confidence": 0.9527145093143586,
    "confidence_tier": "Very High",
    "boosted_score": 0.9526037918994035,
    "base_score": 0.9526037918994035,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Cancer-specific antibody targets tumor marker, not autoimmune pathway"
  },
  {
    "drug": "Aldosterone",
    "disease": "neoplasm of mature b-cells",
    "confidence": 0.9525690739618727,
    "confidence_tier": "Very High",
    "boosted_score": 0.9778354047429275,
    "base_score": 0.8691870264381578,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Hormone promotes tumor growth; blocking it is therapeutic (OPPOSITE)"
  },
  {
    "drug": "Matuzumab",
    "disease": "ulcerative colitis",
    "confidence": 0.9524273919994783,
    "confidence_tier": "Very High",
    "boosted_score": 1.0686417300277509,
    "base_score": 0.9714924818434097,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "autoimmune",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Iratumumab",
    "disease": "ulcerative colitis",
    "confidence": 0.9522889006609206,
    "confidence_tier": "Very High",
    "boosted_score": 0.9717948048332007,
    "base_score": 0.9717948048332007,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "autoimmune",
    "exclusion_reason": "Cancer-specific antibody targets tumor marker, not autoimmune pathway"
  },
  {
    "drug": "Vobarilizumab",
    "disease": "psoriasis",
    "confidence": 0.9508992929608555,
    "confidence_tier": "Very High",
    "boosted_score": 0.948631463919868,
    "base_score": 0.948631463919868,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "IL-6 inhibition is WRONG pathway for psoriasis - need IL-17/IL-23"
  },
  {
    "drug": "Farletuzumab",
    "disease": "psoriasis",
    "confidence": 0.9500930982093206,
    "confidence_tier": "Very High",
    "boosted_score": 0.9823743048272392,
    "base_score": 0.9537614609973196,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Cancer-specific antibody targets tumor marker, not autoimmune pathway"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "pancreatic adenocarcinoma",
    "confidence": 0.9500160702061257,
    "confidence_tier": "Very High",
    "boosted_score": 1.0160410120797247,
    "base_score": 0.9031475662930887,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Olaratumab",
    "disease": "stomach carcinoma in situ",
    "confidence": 0.9498426115044039,
    "confidence_tier": "Very High",
    "boosted_score": 1.0553758443696932,
    "base_score": 0.9381118616619495,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "cancer",
    "exclusion_reason": "FDA approval revoked after confirmatory trial failed"
  },
  {
    "drug": "Doxycycline",
    "disease": "diabetic foot",
    "confidence": 0.949362514217128,
    "confidence_tier": "Very High",
    "boosted_score": 0.8705844045547046,
    "base_score": 0.8493506385899559,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "antibiotic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Enokizumab",
    "disease": "psoriasis",
    "confidence": 0.949357958584925,
    "confidence_tier": "Very High",
    "boosted_score": 0.945366356287619,
    "base_score": 0.945366356287619,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Otelixizumab",
    "disease": "ulcerative colitis",
    "confidence": 0.9487111233023305,
    "confidence_tier": "Very High",
    "boosted_score": 0.964159305351589,
    "base_score": 0.964159305351589,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "autoimmune",
    "exclusion_reason": "Anti-CD3 developed for T1D only, no IBD mechanism"
  },
  {
    "drug": "Ofloxacin",
    "disease": "diabetic ketoacidosis",
    "confidence": 0.9484166853135365,
    "confidence_tier": "Very High",
    "boosted_score": 0.9167164736048597,
    "base_score": 0.8943575352242535,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Daclizumab",
    "disease": "ulcerative colitis",
    "confidence": 0.948060734877369,
    "confidence_tier": "Very High",
    "boosted_score": 1.1279761506877826,
    "base_score": 0.9640821800750277,
    "target_overlap": 2,
    "chemical_sim": 0.0,
    "atc_score": 1.0,
    "drug_type": "biologic",
    "disease_category": "autoimmune",
    "exclusion_reason": "Failed Phase 2 RCT (2006) - 2-7% remission vs 10% placebo"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "esophageal cancer",
    "confidence": 0.9443803405472381,
    "confidence_tier": "Very High",
    "boosted_score": 1.0016777663740124,
    "base_score": 0.8903802367768999,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Sulbenicillin",
    "disease": "diabetes mellitus",
    "confidence": 0.9430946313479722,
    "confidence_tier": "Very High",
    "boosted_score": 0.8698983071279822,
    "base_score": 0.848681275246812,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Farletuzumab",
    "disease": "ulcerative colitis",
    "confidence": 0.9424353284064837,
    "confidence_tier": "Very High",
    "boosted_score": 0.9874446789422497,
    "base_score": 0.9586841543128638,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "autoimmune",
    "exclusion_reason": "Cancer-specific antibody targets tumor marker, not autoimmune pathway"
  },
  {
    "drug": "Volociximab",
    "disease": "psoriasis",
    "confidence": 0.940601505217457,
    "confidence_tier": "Very High",
    "boosted_score": 0.9284286963342705,
    "base_score": 0.9284286963342705,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Matuzumab",
    "disease": "multiple sclerosis",
    "confidence": 0.9396870074408574,
    "confidence_tier": "Very High",
    "boosted_score": 1.0211417532883305,
    "base_score": 0.9283106848075731,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "brain ischemia",
    "confidence": 0.9392035096920397,
    "confidence_tier": "Very High",
    "boosted_score": 0.932943796729477,
    "base_score": 0.8520034673328557,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "drug-induced liver injury",
    "confidence": 0.9388884563693956,
    "confidence_tier": "Very High",
    "boosted_score": 0.9323658370945606,
    "base_score": 0.8514756503146672,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Fontolizumab",
    "disease": "asthma",
    "confidence": 0.9388145167879851,
    "confidence_tier": "Very High",
    "boosted_score": 1.0084198784531404,
    "base_score": 0.9167453440483094,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Aldosterone",
    "disease": "squamous cell carcinoma",
    "confidence": 0.9376941459193223,
    "confidence_tier": "Very High",
    "boosted_score": 1.00101223951963,
    "base_score": 0.881949109708925,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Hormone promotes tumor growth; blocking it is therapeutic (OPPOSITE)"
  },
  {
    "drug": "Matuzumab",
    "disease": "psoriasis",
    "confidence": 0.9370366612493733,
    "confidence_tier": "Very High",
    "boosted_score": 1.016318862095495,
    "base_score": 0.9239262382686318,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "chronic lymphocytic leukemia/small lymphocytic lymphoma",
    "confidence": 0.9358367022931858,
    "confidence_tier": "Very High",
    "boosted_score": 0.9709880253978613,
    "base_score": 0.8867470551578642,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Aldosterone",
    "disease": "carcinoma",
    "confidence": 0.9346266062005579,
    "confidence_tier": "Very High",
    "boosted_score": 0.9961215613555825,
    "base_score": 0.8776401421635088,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Hormone promotes tumor growth; blocking it is therapeutic (OPPOSITE)"
  },
  {
    "drug": "Azidocillin",
    "disease": "diabetes mellitus",
    "confidence": 0.9346189290339777,
    "confidence_tier": "Very High",
    "boosted_score": 0.8839778705338969,
    "base_score": 0.8459118378314803,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Aldosterone",
    "disease": "acute lymphoblastic leukemia",
    "confidence": 0.934415440663556,
    "confidence_tier": "Very High",
    "boosted_score": 0.9871559615267917,
    "base_score": 0.8774719658015927,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Hormone promotes tumor growth; blocking it is therapeutic (OPPOSITE)"
  },
  {
    "drug": "Sibutramine",
    "disease": "osteoarthritis",
    "confidence": 0.9341153545704602,
    "confidence_tier": "Very High",
    "boosted_score": 0.9722776423865247,
    "base_score": 0.8642467932324664,
    "target_overlap": 0,
    "chemical_sim": 0.16,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "autoimmune",
    "exclusion_reason": "Drug withdrawn from US market due to safety concerns"
  },
  {
    "drug": "Ciprofloxacin",
    "disease": "diabetes mellitus",
    "confidence": 0.9325997402108354,
    "confidence_tier": "Very High",
    "boosted_score": 0.9776380157804127,
    "base_score": 0.8538323281925001,
    "target_overlap": 2,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "germ cell tumor",
    "confidence": 0.9316947685684892,
    "confidence_tier": "Very High",
    "boosted_score": 0.9541601675157215,
    "base_score": 0.8875908535029968,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Aldosterone",
    "disease": "urinary bladder cancer",
    "confidence": 0.9314689273016962,
    "confidence_tier": "Very High",
    "boosted_score": 0.9901267587621253,
    "base_score": 0.8723583777639871,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Hormone promotes tumor growth; blocking it is therapeutic (OPPOSITE)"
  },
  {
    "drug": "Bleomycin",
    "disease": "hyperinsulinemic hypoglycemia",
    "confidence": 0.9254476552320064,
    "confidence_tier": "Very High",
    "boosted_score": 0.8286799706672293,
    "base_score": 0.8084682640655897,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "antibiotic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Aldosterone",
    "disease": "metastatic neoplasm",
    "confidence": 0.9252827180580484,
    "confidence_tier": "Very High",
    "boosted_score": 0.9305386294577563,
    "base_score": 0.8271454484068945,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Hormone promotes tumor growth; blocking it is therapeutic (OPPOSITE)"
  },
  {
    "drug": "Vancomycin",
    "disease": "diabetic ketoacidosis",
    "confidence": 0.9246782264104164,
    "confidence_tier": "Very High",
    "boosted_score": 0.8275519242230439,
    "base_score": 0.8073677309493112,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "antibiotic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Lexatumumab",
    "disease": "descending colon cancer",
    "confidence": 0.9226197202177097,
    "confidence_tier": "Very High",
    "boosted_score": 1.0184728557477287,
    "base_score": 0.9175431132862419,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "cancer",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Aldosterone",
    "disease": "metastatic melanoma",
    "confidence": 0.9212466538605563,
    "confidence_tier": "Very High",
    "boosted_score": 0.9746883007595006,
    "base_score": 0.8587562121229081,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Hormone promotes tumor growth; blocking it is therapeutic (OPPOSITE)"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "prostate carcinoma",
    "confidence": 0.9209689792851556,
    "confidence_tier": "Very High",
    "boosted_score": 0.9628175668864521,
    "base_score": 0.8558378372324019,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "metastatic melanoma",
    "confidence": 0.920937834723855,
    "confidence_tier": "Very High",
    "boosted_score": 0.9688905808353935,
    "base_score": 0.8536480888417564,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Minocycline",
    "disease": "diabetic ketoacidosis",
    "confidence": 0.9199620836280756,
    "confidence_tier": "Very High",
    "boosted_score": 0.8208601237040855,
    "base_score": 0.8008391450771566,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "antibiotic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "neoplasm of mature b-cells",
    "confidence": 0.9152835294454154,
    "confidence_tier": "Very High",
    "boosted_score": 0.895397213079,
    "base_score": 0.8177143498438356,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Aducanumab",
    "disease": "psoriatic arthritis",
    "confidence": 0.913907641142405,
    "confidence_tier": "Very High",
    "boosted_score": 0.8957979454728239,
    "base_score": 0.873949215095438,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "autoimmune",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Gentamicin",
    "disease": "diabetic neuropathy",
    "confidence": 0.9138640301848753,
    "confidence_tier": "Very High",
    "boosted_score": 0.8796967605422088,
    "base_score": 0.8260063479269567,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Cisapride",
    "disease": "osteoarthritis",
    "confidence": 0.9125217571339493,
    "confidence_tier": "Very High",
    "boosted_score": 0.9466410675092829,
    "base_score": 0.8414587266749182,
    "target_overlap": 0,
    "chemical_sim": 0.09876543209876543,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "autoimmune",
    "exclusion_reason": "Drug withdrawn from US market due to safety concerns"
  },
  {
    "drug": "Clarithromycin",
    "disease": "diabetic foot",
    "confidence": 0.9118762738496871,
    "confidence_tier": "Very High",
    "boosted_score": 0.8101818889820037,
    "base_score": 0.7904213551043939,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "antibiotic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Troglitazone",
    "disease": "stroke disorder",
    "confidence": 0.9108750527071207,
    "confidence_tier": "Very High",
    "boosted_score": 0.9970092896388989,
    "base_score": 0.8707504713003483,
    "target_overlap": 2,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Drug withdrawn from US market due to safety concerns"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "malignant glioma",
    "confidence": 0.9100807103647106,
    "confidence_tier": "Very High",
    "boosted_score": 0.9025706013260906,
    "base_score": 0.802284978956525,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Levofloxacin",
    "disease": "diabetic ketoacidosis",
    "confidence": 0.9077326651737971,
    "confidence_tier": "Very High",
    "boosted_score": 0.8531634344721336,
    "base_score": 0.8323545702167158,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Fontolizumab",
    "disease": "urothelial carcinoma",
    "confidence": 0.9059513829134914,
    "confidence_tier": "Very High",
    "boosted_score": 1.0030227860549683,
    "base_score": 0.9118388964136075,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "cancer",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Fontolizumab",
    "disease": "psoriatic arthritis",
    "confidence": 0.9034092667520334,
    "confidence_tier": "Very High",
    "boosted_score": 0.9780230218951967,
    "base_score": 0.8891118380865424,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "autoimmune",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Bectumomab",
    "disease": "descending colon cancer",
    "confidence": 0.9033991917125439,
    "confidence_tier": "Very High",
    "boosted_score": 0.9177024989677932,
    "base_score": 0.9177024989677932,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "cancer",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Fontolizumab",
    "disease": "malignant glioma",
    "confidence": 0.9028788863453955,
    "confidence_tier": "Very High",
    "boosted_score": 0.9607210205995717,
    "base_score": 0.865514432972587,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "diabetes mellitus",
    "confidence": 0.9012675847550791,
    "confidence_tier": "Very High",
    "boosted_score": 0.8939536206495493,
    "base_score": 0.7946254405773772,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "mantle cell lymphoma",
    "confidence": 0.9004189959823555,
    "confidence_tier": "Very High",
    "boosted_score": 0.9207838990247931,
    "base_score": 0.8408985379221855,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Dextropropoxyphene",
    "disease": "agoraphobia",
    "confidence": 0.8995238818402549,
    "confidence_tier": "Very High",
    "boosted_score": 0.9054219906856806,
    "base_score": 0.7977286261547847,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Drug withdrawn from US market due to safety concerns"
  },
  {
    "drug": "Cerivastatin",
    "disease": "hyperlipidemia",
    "confidence": 0.8915079265300613,
    "confidence_tier": "Very High",
    "boosted_score": 0.8486882405166678,
    "base_score": 0.8044438298736188,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Drug withdrawn from US market due to safety concerns"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "acute lymphoblastic leukemia",
    "confidence": 0.8898678959083732,
    "confidence_tier": "Very High",
    "boosted_score": 0.9135726648891036,
    "base_score": 0.8267625926598223,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Valdecoxib",
    "disease": "bipolar disorder",
    "confidence": 0.888811668961377,
    "confidence_tier": "Very High",
    "boosted_score": 0.8503545345877856,
    "base_score": 0.755870697411365,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "kinase_inhibitor",
    "disease_category": "other",
    "exclusion_reason": "Drug withdrawn from US market due to safety concerns"
  },
  {
    "drug": "3-(4-nitrophenyl)-1H-pyrazole",
    "disease": "diabetic nephropathy",
    "confidence": 0.8849351984931172,
    "confidence_tier": "Very High",
    "boosted_score": 0.8653497617262345,
    "base_score": 0.8241426302154613,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Aducanumab",
    "disease": "malignant glioma",
    "confidence": 0.8835000281328736,
    "confidence_tier": "Very High",
    "boosted_score": 0.8412306706348843,
    "base_score": 0.8207128493998872,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Aducanumab",
    "disease": "neoplasm of mature b-cells",
    "confidence": 0.8818754528381517,
    "confidence_tier": "Very High",
    "boosted_score": 0.8396361930484669,
    "base_score": 0.8191572615106996,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Doxycycline",
    "disease": "diabetic retinopathy",
    "confidence": 0.8810750026802013,
    "confidence_tier": "Very High",
    "boosted_score": 0.8184278394564277,
    "base_score": 0.727491412850158,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "antibiotic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Aldosterone",
    "disease": "adrenal cortex carcinoma",
    "confidence": 0.8797215203925347,
    "confidence_tier": "Very High",
    "boosted_score": 0.9179871904867196,
    "base_score": 0.8087992867724402,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Hormone promotes tumor growth; blocking it is therapeutic (OPPOSITE)"
  },
  {
    "drug": "Olaratumab",
    "disease": "malignant glioma",
    "confidence": 0.8791991949543267,
    "confidence_tier": "Very High",
    "boosted_score": 0.9130967977452248,
    "base_score": 0.8044905707006386,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "FDA approval revoked after confirmatory trial failed"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "coronary artery disease",
    "confidence": 0.87744069458242,
    "confidence_tier": "Very High",
    "boosted_score": 0.8208607312018964,
    "base_score": 0.8008397377579478,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Neomycin",
    "disease": "diabetic ketoacidosis",
    "confidence": 0.876161329445831,
    "confidence_tier": "Very High",
    "boosted_score": 0.7715428924646408,
    "base_score": 0.752724773136235,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "antibiotic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Farletuzumab",
    "disease": "psoriatic arthritis",
    "confidence": 0.8738001056587306,
    "confidence_tier": "Very High",
    "boosted_score": 0.9046970602996275,
    "base_score": 0.8699010195188726,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "autoimmune",
    "exclusion_reason": "Cancer-specific antibody targets tumor marker, not autoimmune pathway"
  },
  {
    "drug": "Technetium Tc-99M sulfur colloid",
    "disease": "gaucher disease",
    "confidence": 0.8689151294633435,
    "confidence_tier": "Very High",
    "boosted_score": 0.8074489071695689,
    "base_score": 0.8074489071695689,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Amoxicillin",
    "disease": "diabetic ketoacidosis",
    "confidence": 0.8684259584481726,
    "confidence_tier": "Very High",
    "boosted_score": 0.7958082725162852,
    "base_score": 0.7763983146500344,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "chronic myelogenous leukemia bcr-abl1 positive",
    "confidence": 0.8683872591897854,
    "confidence_tier": "Very High",
    "boosted_score": 0.8966790159554766,
    "base_score": 0.8041964268658983,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Bectumomab",
    "disease": "metastatic melanoma",
    "confidence": 0.8683261987558119,
    "confidence_tier": "Very High",
    "boosted_score": 0.8826396747298297,
    "base_score": 0.8826396747298297,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "cancer",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Bectumomab",
    "disease": "urothelial carcinoma",
    "confidence": 0.8664719626827551,
    "confidence_tier": "Very High",
    "boosted_score": 0.8810215678064239,
    "base_score": 0.8810215678064239,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "cancer",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Lexatumumab",
    "disease": "psoriatic arthritis",
    "confidence": 0.8653926027139184,
    "confidence_tier": "Very High",
    "boosted_score": 0.9257058815656825,
    "base_score": 0.8415508014233476,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "autoimmune",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Lexatumumab",
    "disease": "urothelial carcinoma",
    "confidence": 0.8641883623113412,
    "confidence_tier": "Very High",
    "boosted_score": 0.9476891380197142,
    "base_score": 0.861535580017922,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "cancer",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Ceftaroline fosamil",
    "disease": "diabetes mellitus",
    "confidence": 0.8598732942791986,
    "confidence_tier": "Very High",
    "boosted_score": 0.7857144539312749,
    "base_score": 0.7665506867622195,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Olaratumab",
    "disease": "urothelial carcinoma",
    "confidence": 0.8579368806325438,
    "confidence_tier": "Very High",
    "boosted_score": 0.9337954002958387,
    "base_score": 0.8300403558185233,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "cancer",
    "exclusion_reason": "FDA approval revoked after confirmatory trial failed"
  },
  {
    "drug": "Olaratumab",
    "disease": "metastatic melanoma",
    "confidence": 0.8570576304127018,
    "confidence_tier": "Very High",
    "boosted_score": 1.0182636534520928,
    "base_score": 0.8778134943552522,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 1.0,
    "drug_type": "biologic",
    "disease_category": "cancer",
    "exclusion_reason": "FDA approval revoked after confirmatory trial failed"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "squamous cell lung carcinoma",
    "confidence": 0.8543257349844844,
    "confidence_tier": "Very High",
    "boosted_score": 0.890362294734084,
    "base_score": 0.7914331508747413,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Olaratumab",
    "disease": "cervical carcinoma",
    "confidence": 0.8542465443064944,
    "confidence_tier": "Very High",
    "boosted_score": 0.9306086599096188,
    "base_score": 0.827207697697439,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "cancer",
    "exclusion_reason": "FDA approval revoked after confirmatory trial failed"
  },
  {
    "drug": "Matuzumab",
    "disease": "pulmonary arterial hypertension associated with congenital heart disease",
    "confidence": 0.8506257619536963,
    "confidence_tier": "Very High",
    "boosted_score": 0.8781380643258875,
    "base_score": 0.8206897797438201,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "metastatic neoplasm",
    "confidence": 0.8453936522209534,
    "confidence_tier": "Very High",
    "boosted_score": 0.8388451520051958,
    "base_score": 0.7456401351157296,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Pergolide",
    "disease": "urticaria",
    "confidence": 0.8442158299222234,
    "confidence_tier": "Very High",
    "boosted_score": 0.83552447881692,
    "base_score": 0.74268842561504,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Drug withdrawn from US market due to safety concerns"
  },
  {
    "drug": "Flucloxacillin",
    "disease": "diabetic ketoacidosis",
    "confidence": 0.8424451997658854,
    "confidence_tier": "Very High",
    "boosted_score": 0.7744072517793348,
    "base_score": 0.7555192700286194,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "lung cancer",
    "confidence": 0.8394233875469808,
    "confidence_tier": "Very High",
    "boosted_score": 0.8793113974104034,
    "base_score": 0.7816101310314697,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Cerivastatin",
    "disease": "conjunctivitis",
    "confidence": 0.8278158631499616,
    "confidence_tier": "Very High",
    "boosted_score": 0.7803927857920765,
    "base_score": 0.761358815406904,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Drug withdrawn from US market due to safety concerns"
  },
  {
    "drug": "Bectumomab",
    "disease": "malignant glioma",
    "confidence": 0.8273065308801951,
    "confidence_tier": "Very High",
    "boosted_score": 0.8084276332001115,
    "base_score": 0.8084276332001115,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Matuzumab",
    "disease": "psoriatic arthritis",
    "confidence": 0.822945352830498,
    "confidence_tier": "Very High",
    "boosted_score": 0.9149637262443917,
    "base_score": 0.8317852056767197,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "autoimmune",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Fontolizumab",
    "disease": "primary brain neoplasm",
    "confidence": 0.8191737918625898,
    "confidence_tier": "Very High",
    "boosted_score": 0.8794532076485146,
    "base_score": 0.7995029160441042,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "hypersensitivity reaction disease",
    "confidence": 0.8190375067313024,
    "confidence_tier": "Very High",
    "boosted_score": 0.7829142617484558,
    "base_score": 0.7492002504769912,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Technetium Tc-99m mebrofenin",
    "disease": "pulmonary arterial hypertension associated with congenital heart disease",
    "confidence": 0.8175910447757143,
    "confidence_tier": "Very High",
    "boosted_score": 0.7681754090504335,
    "base_score": 0.7681754090504335,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Aldosterone",
    "disease": "cancer",
    "confidence": 0.8121962466951114,
    "confidence_tier": "Very High",
    "boosted_score": 0.8875215303899284,
    "base_score": 0.7489633167847497,
    "target_overlap": 6,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Hormone promotes tumor growth; blocking it is therapeutic (OPPOSITE)"
  },
  {
    "drug": "Fosfomycin",
    "disease": "diabetic ketoacidosis",
    "confidence": 0.8116842420173168,
    "confidence_tier": "Very High",
    "boosted_score": 0.7211770536987316,
    "base_score": 0.7035873694621773,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "antibiotic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "carcinoma",
    "confidence": 0.8116387638951439,
    "confidence_tier": "Very High",
    "boosted_score": 0.8626493622605301,
    "base_score": 0.7600434909784406,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Volociximab",
    "disease": "malignant glioma",
    "confidence": 0.807922169917252,
    "confidence_tier": "Very High",
    "boosted_score": 0.7953703675948885,
    "base_score": 0.7953703675948885,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Lexatumumab",
    "disease": "malignant glioma",
    "confidence": 0.8055121659806335,
    "confidence_tier": "Very High",
    "boosted_score": 0.8623389352613733,
    "base_score": 0.7768819236588947,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Aldosterone",
    "disease": "indolent b-cell non-hodgkin lymphoma",
    "confidence": 0.8014048445099852,
    "confidence_tier": "Very High",
    "boosted_score": 0.8494099465597199,
    "base_score": 0.7550310636086399,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Hormone promotes tumor growth; blocking it is therapeutic (OPPOSITE)"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "skin cancer",
    "confidence": 0.7948729733746233,
    "confidence_tier": "High",
    "boosted_score": 0.8318110844393686,
    "base_score": 0.7596448259720261,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Tetracycline",
    "disease": "diabetic foot",
    "confidence": 0.788482608946005,
    "confidence_tier": "High",
    "boosted_score": 0.7064215475196383,
    "base_score": 0.6891917536776959,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "antibiotic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Cerivastatin",
    "disease": "diabetes mellitus",
    "confidence": 0.7871687206573401,
    "confidence_tier": "High",
    "boosted_score": 0.8822939040990655,
    "base_score": 0.7605981931888495,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 1.0,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Drug withdrawn from US market due to safety concerns"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "small cell lung carcinoma",
    "confidence": 0.7860538000824576,
    "confidence_tier": "High",
    "boosted_score": 0.8304551334585,
    "base_score": 0.7515431072022625,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Enokizumab",
    "disease": "urothelial carcinoma",
    "confidence": 0.7847954220852431,
    "confidence_tier": "High",
    "boosted_score": 0.8231802320672938,
    "base_score": 0.8231802320672938,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "cancer",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Fluconazole",
    "disease": "diabetic ketoacidosis",
    "confidence": 0.7841938361365015,
    "confidence_tier": "High",
    "boosted_score": 0.7519413345184857,
    "base_score": 0.7336013019692543,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "mediastinal malignant lymphoma",
    "confidence": 0.7830152281670822,
    "confidence_tier": "High",
    "boosted_score": 0.8327578892434798,
    "base_score": 0.7468680621017756,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Gadolinium, elemental",
    "disease": "scheie syndrome",
    "confidence": 0.7802874319183197,
    "confidence_tier": "High",
    "boosted_score": 0.7448125215174114,
    "base_score": 0.7448125215174114,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "testicular germ cell tumor",
    "confidence": 0.7794014465510105,
    "confidence_tier": "High",
    "boosted_score": 0.8092830635489408,
    "base_score": 0.7598902005154373,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Olaratumab",
    "disease": "pancreatic adenocarcinoma",
    "confidence": 0.7745081151652341,
    "confidence_tier": "High",
    "boosted_score": 0.8737626783847621,
    "base_score": 0.7766779363420108,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "biologic",
    "disease_category": "cancer",
    "exclusion_reason": "FDA approval revoked after confirmatory trial failed"
  },
  {
    "drug": "Idarubicin",
    "disease": "diabetic ketoacidosis",
    "confidence": 0.7672081001406829,
    "confidence_tier": "High",
    "boosted_score": 0.7420158764386039,
    "base_score": 0.7239179282327843,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Chemotherapy drug has no mechanism for metabolic disease"
  },
  {
    "drug": "Technetium Tc-99M sulfur colloid",
    "disease": "scabies",
    "confidence": 0.7622315683791125,
    "confidence_tier": "High",
    "boosted_score": 0.7345357954805213,
    "base_score": 0.7345357954805213,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "atherosclerosis",
    "confidence": 0.7597344761312355,
    "confidence_tier": "High",
    "boosted_score": 0.7788066685683297,
    "base_score": 0.6922725942829597,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Ciprofloxacin",
    "disease": "diabetic ketoacidosis",
    "confidence": 0.7571524643224921,
    "confidence_tier": "High",
    "boosted_score": 0.7363771929240494,
    "base_score": 0.7184167735844385,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Technetium Tc-99M sulfur colloid",
    "disease": "coronary atherosclerosis",
    "confidence": 0.7541388027047359,
    "confidence_tier": "High",
    "boosted_score": 0.7301050987581217,
    "base_score": 0.7301050987581217,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Bectumomab",
    "disease": "pulmonary arterial hypertension associated with congenital heart disease",
    "confidence": 0.7508614814878306,
    "confidence_tier": "High",
    "boosted_score": 0.7619119194231918,
    "base_score": 0.7619119194231918,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Levofloxacin",
    "disease": "diabetic foot",
    "confidence": 0.7465227388938602,
    "confidence_tier": "High",
    "boosted_score": 0.7305864180252375,
    "base_score": 0.7127672370977928,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Gentamicin",
    "disease": "diabetic retinopathy",
    "confidence": 0.7436731641749316,
    "confidence_tier": "High",
    "boosted_score": 0.7290615937866722,
    "base_score": 0.7112796036943144,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Azithromycin",
    "disease": "diabetic ketoacidosis",
    "confidence": 0.7428364552535126,
    "confidence_tier": "High",
    "boosted_score": 0.6805018268846157,
    "base_score": 0.6639042213508446,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "antibiotic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Aldosterone",
    "disease": "gestational choriocarcinoma",
    "confidence": 0.7422670880007195,
    "confidence_tier": "High",
    "boosted_score": 0.8164823479712883,
    "base_score": 0.7257620870855895,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "cancer",
    "exclusion_reason": "Hormone promotes tumor growth; blocking it is therapeutic (OPPOSITE)"
  },
  {
    "drug": "Matuzumab",
    "disease": "urothelial carcinoma",
    "confidence": 0.7403170093989148,
    "confidence_tier": "High",
    "boosted_score": 0.890731974884993,
    "base_score": 0.8024612386351287,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "cancer",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Dirithromycin",
    "disease": "diabetic ketoacidosis",
    "confidence": 0.7391306479492822,
    "confidence_tier": "High",
    "boosted_score": 0.678539480935919,
    "base_score": 0.6619897374984576,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "antibiotic",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Ioflupane I 123",
    "disease": "cystitis",
    "confidence": 0.738637619805679,
    "confidence_tier": "High",
    "boosted_score": 0.7623738281880857,
    "base_score": 0.7260703125600816,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Enokizumab",
    "disease": "rabies",
    "confidence": 0.734983669147133,
    "confidence_tier": "High",
    "boosted_score": 0.7535656663022396,
    "base_score": 0.7535656663022396,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Matuzumab",
    "disease": "cervical carcinoma",
    "confidence": 0.7326840080485576,
    "confidence_tier": "High",
    "boosted_score": 0.8865745062207446,
    "base_score": 0.7987157713700401,
    "target_overlap": 1,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "cancer",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "Iodixanol",
    "disease": "hypercholesterolemia",
    "confidence": 0.7291896142493106,
    "confidence_tier": "High",
    "boosted_score": 0.7376568000280331,
    "base_score": 0.6926354929840687,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Metronidazole",
    "disease": "diabetic ketoacidosis",
    "confidence": 0.7291670473085488,
    "confidence_tier": "High",
    "boosted_score": 0.721464969667716,
    "base_score": 0.7038682630904547,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "bone paget disease",
    "confidence": 0.7270478562410584,
    "confidence_tier": "High",
    "boosted_score": 0.7285124228533234,
    "base_score": 0.697141074500788,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Fludeoxyglucose (18F)",
    "disease": "dermatitis",
    "confidence": 0.7162987724265808,
    "confidence_tier": "High",
    "boosted_score": 0.7189930974278111,
    "base_score": 0.694679321186291,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Diagnostic agent (for imaging, not treatment)"
  },
  {
    "drug": "Gentamicin",
    "disease": "diabetic foot",
    "confidence": 0.7157668399727857,
    "confidence_tier": "High",
    "boosted_score": 0.7146718983428252,
    "base_score": 0.6972408764320246,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Bectumomab",
    "disease": "paroxysmal nocturnal hemoglobinuria",
    "confidence": 0.7110860883473283,
    "confidence_tier": "High",
    "boosted_score": 0.7415823487819572,
    "base_score": 0.7415823487819572,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "biologic",
    "disease_category": "other",
    "exclusion_reason": "Drug development discontinued - not available"
  },
  {
    "drug": "XYLOSE-DERIVED IMIDAZOLE",
    "disease": "hyperglycemia",
    "confidence": 0.7104316960820024,
    "confidence_tier": "High",
    "boosted_score": 0.7269254926820597,
    "base_score": 0.7269254926820597,
    "target_overlap": 0,
    "chemical_sim": 0.0,
    "atc_score": 0.0,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Antibiotics can inhibit insulin release or worsen glucose control"
  },
  {
    "drug": "Troglitazone",
    "disease": "atopic eczema",
    "confidence": 0.7021187352462847,
    "confidence_tier": "High",
    "boosted_score": 0.8428436015746033,
    "base_score": 0.7234709026391444,
    "target_overlap": 4,
    "chemical_sim": 0.0,
    "atc_score": 0.5,
    "drug_type": "small_molecule",
    "disease_category": "other",
    "exclusion_reason": "Drug withdrawn from US market due to safety concerns"
  }
]